Global Hepatitis C Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: G4CA129371C2EN
QYResearch

Abstracts

This report focuses on the global Hepatitis C Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis C Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• AbbVie
• Gilead
• Kenilworth
• Merck
• Johnson & Johnson
• Bristol-Myers Squibb
• ...

Market segment by Type, the product can be split into

• Rx
• OTC

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hepatitis C Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hepatitis C Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hepatitis C Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis C Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hepatitis C Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rx
  1.4.3 OTC
1.5 Market by Application
  1.5.1 Global Hepatitis C Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hepatitis C Treatment Market Perspective (2015-2026)
2.2 Hepatitis C Treatment Growth Trends by Regions
  2.2.1 Hepatitis C Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hepatitis C Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hepatitis C Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hepatitis C Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hepatitis C Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hepatitis C Treatment Players by Market Size
  3.1.1 Global Top Hepatitis C Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hepatitis C Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hepatitis C Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis C Treatment Market Concentration Ratio
  3.2.1 Global Hepatitis C Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hepatitis C Treatment Revenue in 2019
3.3 Hepatitis C Treatment Key Players Head office and Area Served
3.4 Key Players Hepatitis C Treatment Product Solution and Service
3.5 Date of Enter into Hepatitis C Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hepatitis C Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis C Treatment Forecasted Market Size by Type (2021-2026)

5 HEPATITIS C TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hepatitis C Treatment Market Size by Application (2015-2020)
5.2 Global Hepatitis C Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hepatitis C Treatment Market Size (2015-2020)
6.2 Hepatitis C Treatment Key Players in North America (2019-2020)
6.3 North America Hepatitis C Treatment Market Size by Type (2015-2020)
6.4 North America Hepatitis C Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hepatitis C Treatment Market Size (2015-2020)
7.2 Hepatitis C Treatment Key Players in Europe (2019-2020)
7.3 Europe Hepatitis C Treatment Market Size by Type (2015-2020)
7.4 Europe Hepatitis C Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hepatitis C Treatment Market Size (2015-2020)
8.2 Hepatitis C Treatment Key Players in China (2019-2020)
8.3 China Hepatitis C Treatment Market Size by Type (2015-2020)
8.4 China Hepatitis C Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hepatitis C Treatment Market Size (2015-2020)
9.2 Hepatitis C Treatment Key Players in Japan (2019-2020)
9.3 Japan Hepatitis C Treatment Market Size by Type (2015-2020)
9.4 Japan Hepatitis C Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hepatitis C Treatment Market Size (2015-2020)
10.2 Hepatitis C Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis C Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis C Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hepatitis C Treatment Market Size (2015-2020)
11.2 Hepatitis C Treatment Key Players in India (2019-2020)
11.3 India Hepatitis C Treatment Market Size by Type (2015-2020)
11.4 India Hepatitis C Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hepatitis C Treatment Market Size (2015-2020)
12.2 Hepatitis C Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis C Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis C Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview and Its Total Revenue
  13.1.3 AbbVie Hepatitis C Treatment Introduction
  13.1.4 AbbVie Revenue in Hepatitis C Treatment Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Gilead
  13.2.1 Gilead Company Details
  13.2.2 Gilead Business Overview and Its Total Revenue
  13.2.3 Gilead Hepatitis C Treatment Introduction
  13.2.4 Gilead Revenue in Hepatitis C Treatment Business (2015-2020)
  13.2.5 Gilead Recent Development
13.3 Kenilworth
  13.3.1 Kenilworth Company Details
  13.3.2 Kenilworth Business Overview and Its Total Revenue
  13.3.3 Kenilworth Hepatitis C Treatment Introduction
  13.3.4 Kenilworth Revenue in Hepatitis C Treatment Business (2015-2020)
  13.3.5 Kenilworth Recent Development
13.4 Merck
  13.4.1 Merck Company Details
  13.4.2 Merck Business Overview and Its Total Revenue
  13.4.3 Merck Hepatitis C Treatment Introduction
  13.4.4 Merck Revenue in Hepatitis C Treatment Business (2015-2020)
  13.4.5 Merck Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson Hepatitis C Treatment Introduction
  13.5.4 Johnson & Johnson Revenue in Hepatitis C Treatment Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Details
  13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.6.3 Bristol-Myers Squibb Hepatitis C Treatment Introduction
  13.6.4 Bristol-Myers Squibb Revenue in Hepatitis C Treatment Business (2015-2020)
  13.6.5 Bristol-Myers Squibb Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hepatitis C Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis C Treatment Revenue
Table 3. Ranking of Global Top Hepatitis C Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis C Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rx
Table 6. Key Players of OTC
Table 7. Global Hepatitis C Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis C Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hepatitis C Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hepatitis C Treatment Market Share by Regions (2015-2020)
Table 11. Global Hepatitis C Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hepatitis C Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hepatitis C Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Hepatitis C Treatment Players
Table 18. Global Hepatitis C Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hepatitis C Treatment Market Share by Players (2015-2020)
Table 20. Global Top Hepatitis C Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Treatment as of 2019)
Table 21. Global Hepatitis C Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hepatitis C Treatment Product Solution and Service
Table 24. Date of Enter into Hepatitis C Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hepatitis C Treatment Market Size Share by Type (2015-2020)
Table 28. Global Hepatitis C Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Hepatitis C Treatment Market Size Share by Application (2015-2020)
Table 30. Global Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hepatitis C Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 34. North America Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hepatitis C Treatment Market Share by Type (2015-2020)
Table 36. North America Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hepatitis C Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 40. Europe Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hepatitis C Treatment Market Share by Type (2015-2020)
Table 42. Europe Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hepatitis C Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 46. China Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Hepatitis C Treatment Market Share by Type (2015-2020)
Table 48. China Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Hepatitis C Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 52. Japan Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hepatitis C Treatment Market Share by Type (2015-2020)
Table 54. Japan Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hepatitis C Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 58. Southeast Asia Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hepatitis C Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hepatitis C Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 64. India Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Hepatitis C Treatment Market Share by Type (2015-2020)
Table 66. India Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Hepatitis C Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hepatitis C Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hepatitis C Treatment Market Share (2019-2020)
Table 70. Central & South America Hepatitis C Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hepatitis C Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Hepatitis C Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hepatitis C Treatment Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Gilead Company Details
Table 80. Gilead Business Overview
Table 81. Gilead Product
Table 82. Gilead Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 83. Gilead Recent Development
Table 84. Kenilworth Company Details
Table 85. Kenilworth Business Overview
Table 86. Kenilworth Product
Table 87. Kenilworth Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 88. Kenilworth Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Product
Table 102. Bristol-Myers Squibb Revenue in Hepatitis C Treatment Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hepatitis C Treatment Market Share by Type: 2020 VS 2026
Figure 2. Rx Features
Figure 3. OTC Features
Figure 4. Global Hepatitis C Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Hepatitis C Treatment Report Years Considered
Figure 9. Global Hepatitis C Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hepatitis C Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Hepatitis C Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hepatitis C Treatment Market Share by Players in 2019
Figure 14. Global Top Hepatitis C Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Treatment Revenue in 2019
Figure 16. North America Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hepatitis C Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 25. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Gilead Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 27. Kenilworth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kenilworth Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 33. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Treatment Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed